Company profile · free preview

Labcorp

LH · Updated 11/13/2026

Revenue

$14.0B

Fiscal 2025

Net income

$876.5M

Fiscal 2025

Free cash flow

$1.2B

Fiscal 2025

Net cash / (debt)

—

Fiscal 2025

Five-year financials

Fiscal year20252024202320212020
Revenue$14.0B$13.0B$12.2B$16.1B$14.0B
Net income$876.5M$746.0M$418.0M$2.4B$1.6B
Diluted EPS—————
Operating cash flow$1.6B$1.6B$1.3B$3.1B$2.1B
Free cash flow$1.2B$1.1B$874.1M$2.6B$1.8B
Cash$532.3M$1.5B$536.8M$1.5B$1.3B
Total debt—————

Financial trends

Historical · FY2020–FY2025

Source: Reported annual filings (10-K / 20-F) and provider data. Fiscal years as reported; margins are calculated from the reported figures shown.

Want the story behind these numbers? Ask Osiris anything about Labcorp's filings — free.

Create free account

Where the cash went

Cumulative, fiscal 2020–2025, straight from the reported cash-flow statements.

Reinvested in capex

22.7%

of operating cash flow

Returned to owners

—

of free cash flow (buybacks + dividends)

Diluted share count

—

change 2020–2025

Capital expenditure $2.2BBar width = share of $9.8B operating cash flow
Operating cash flow$9.8B
Capital expenditure($2.2B)
Free cash flow$7.6B
Share buybacks—
Dividends paid—
Acquisitions (net)—
Net debt issued / (repaid)—
Stock-based compensation (non-cash)—

"—" means a year didn't report that line, so no total is shown rather than an estimate.

Labcorp return on capital (fiscal 2025)

ROIC

7.1%

Return on capital

6.9%

Return on equity

10.5%

Return on assets

4.8%

Gross margin

28.8%

Operating margin

10.9%

Net debt / EBITDA

2.45x

Labcorp insider buying and selling

Recent open-market trades reported on Form 4. Context only — not a reason to buy or sell.

DateInsiderTypeSharesPrice
2026-11-03Vaughn Bryan TSale306$353.70
2026-10-30Parham Richelle PSale1,078$361.22

SEC filings

No filings stored yet.

Ask anything about Labcorp's filings

"What changed since last year?" "Where is the cash going?" Get answers drawn straight from the filings.

Start researching free

Compare LH head-to-head

More companies